Related Experiment Video
Updated: Jan 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
An association between antibiotic usage during pregnancy and the subsequent development of autoimmune hepatitis
Gerald Y Minuk1,2, Lindsay E Nicolle1,3, Marina Yogendran4
1Departments of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Background:
Whether the incidence of autoimmune hepatitis (AIH) is higher in women prescribed antibiotics during pregnancy remains to be determined.
Methods:
Administrative databases and hospital abstracts were reviewed to identify all pregnant women in the province of Manitoba from 1996 to 2001 who were prescribed antibiotics during pregnancy and subsequently diagnosed with AIH until 2020.
Results:
In this study, 70,666 pregnant women were identified during the 5-year period. Antibiotics were prescribed in 11,654 (16.5%). AIH was subsequently diagnosed in more mothers who were prescribed antibiotics than in those who were not (82/11,654 [0.7%] versus 166/58,975 [0.28%], p <0.0001). The number of antibiotic prescriptions was higher in mothers who subsequently developed AIH than in those who were prescribed antibiotics but did not develop AIH (0.56 [SD 1.09] versus 0.24 [SD 0.67], p <0.0001) as were the prescribed durations of treatment (4.19 [SD 7.72] versus 2.03 [SD 7.55] days, p <0.0001). The mean ages (25.9 [SD 6.0] and 26.8 [SD 5.8]; years) and times to AIH diagnosis (10.6 [SD 4.9] and 10.8 [SD 4.8] years) were similar in mothers who were prescribed and not prescribed antibiotics and developed AIH. The relative risk of developing AIH in antibiotic recipients was 2.5 (95% CI 1.92-3.25, p <0.0001), and the hazard ratio was 2.58 (95% CI 1.98-3.36, p <0.001).
Conclusions:
These results describe an association between mothers prescribed antibiotics during pregnancy and the subsequent development of AIH.
More Related Videos
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
07:13Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Teratogenicity
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents